Brisbane, Australia, February 7th, 2015
Admedus Limited (ASX: AHZ) today announced that Mr Lee Rodne, Chief Executive Officer, will present a company overview at three upcoming investor conferences in New York City:
?? BIO CEO & Investor Conference on Monday, February 9th at 8:00am, US eastern time
?? 2015 Leerink Global Healthcare Conference, Wednesday, February 11th at 8:00am, US eastern time
?? ASX Spotlight conference Thursday, March 5th
Mr Rodne will provide the investor audience with an overview of Admedus, the strength of the company’s portfolio and the key milestones ahead for the company.
The presentation will primarily focus on CardioCel®, Admedus’ cardiovascular scaffold, and the company’s immunotherapies programmes.
CardioCel®, is being used by cardiac surgeons around the world to repair complex heart defects. It is on the market in the US, Europe and Canada, and is also being used under Early Access Programmes in Asia and Australia.
The product has received positive reviews from medical professionals around the world at several international conferences.
Follow us:
Twitter: @Admedus
Facebook: www.facebook.com/pages/Admedus
For more information, please contact:
Dr Julian Chick | Chief Operating Officer | Admedus Limited
Tel: +61 3 9620 5454
Media:
Haley Price
+61 (0) 423 139 163
hprice@admedus.com
Media Europe & Asia
Consilium Strategic Communications
Jessica Hodgson / Ivar Milligan
+44 (0)20 3709 5700
admedus@consilium-comms.com
About Admedus Limited
Admedus (ASX: AHZ) is a diversified, global healthcare company. Our focus is on investing in and developing next generation technologies with world class partners, acquiring strategic assets to grow product and service offerings and expanding revenues from our existing, profitable medical sales and distribution business. The company has assets from research & development through clinical development as well as sales, marketing and distribution. Admedus is in the process of commercialising its innovative tissue engineering technology for regenerative medicine. We also have a major interest in developing the next generation of vaccines with a Brisbane-based research group lead by Professor Ian Frazer. The vaccine programmes target disease with significant global potential, such as Herpes and Human Papillomavirus.
Further information on the company can be found on www.admedus.com
Help employers find you! Check out all the jobs and post your resume.
